文献速递角膜与眼表疾病

干眼干预措施:系统评价的概况

Interventions for Dry Eye: An Overview of Systematic Reviews.
PubMed 文献 · JAMA Ophthalmol · 2024-01-01

该概况旨在总结干眼干预措施可靠系统评价的结果并突出证据缺口。检索Cochrane眼与视觉美国卫星数据库,纳入2016至2022年发表的可靠系统评价。共鉴定138篇可能相关的系统评价,71篇符合纳入标准,其中26篇(37%)被评估为可靠。在可靠系统评价中,未发现任何干眼干预措施的确定性证据,但不确定证据提示多种干预可能有效。

要点

  • 26篇(37%)系统评价被评估为可靠,但无任何干眼干预措施获得确定性证据。
  • 不确定证据提示环境调整、饮食调整、人工泪液和润滑剂、泪点封闭、强脉冲光治疗、矢量热脉动治疗(Lipiflow)、局部皮质类固醇、局部环孢素A、局部促分泌剂和自体血清可能有效。
  • 仅不可靠系统评价评估了lifitegrast、口服抗生素和湿房装置。

核心结论

  • 该概况发现一些证据表明干眼干预措施可能有效,但无确定性证据可用。
  • 大多数干眼干预措施系统评价的实施和报告有待改进,需要可靠系统评价来评估lifitegrast、口服抗生素和湿房装置。

研究设计与样本

  • 研究为系统评价的概况,检索Cochrane眼与视觉美国卫星数据库,纳入2016至2022年发表的评估干眼干预措施的可靠系统评价。
  • 共鉴定138篇可能相关的系统评价,71篇被认为符合条件,26篇(37%)被评估为可靠。

主要发现

  • 在可靠系统评价中,未发现任何干眼干预措施的确定性证据。
  • 不确定证据提示环境调整、饮食调整、人工泪液和润滑剂、泪点封闭、强脉冲光治疗、矢量热脉动治疗(Lipiflow)、局部皮质类固醇、局部环孢素A、局部促分泌剂和自体血清可能有效。
  • 仅不可靠系统评价评估了lifitegrast、口服抗生素和湿房装置。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 在可靠系统评价中,未发现任何干眼干预措施的确定性证据。
  • 大多数干眼干预措施系统评价的实施和报告有待改进,需要可靠系统评价来评估lifitegrast、口服抗生素和湿房装置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Dry eye is a common ocular disease that can have substantial morbidity. Systematic reviews provide evidence for dry eye interventions and can be useful for patients, clinicians, and clinical guideline developers. Overviews of reviews use explicit and systematic methods to synthesize findings from multiple systematic reviews, but currently, there are no overviews of systematic reviews investigating interventions for dry eye. OBJECTIVE: To summarize the results of reliable systematic reviews of dry eye interventions and to highlight the evidence gaps identified. EVIDENCE REVIEW: We searched the Cochrane Eyes and Vision US satellite database and included reliable systematic reviews evaluating dry eye interventions published from 2016 to 2022. We reported the proportion of systematic reviews that were reliable with reasons for unreliability. Critical and important outcomes from reliable systematic reviews were extracted and verified. Critical outcomes included dry eye-related patient-reported outcome measures. Results were synthesized from reliable systematic reviews to provide summaries of evidence for each intervention. Evidence for each intervention was defined as conclusive or inconclusive depending on whether high-certainty evidence across systematic reviews was available according to Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) criteria and whether findings reached statistical or clinical significance. Recommendations were made for further research. FINDINGS: Within the Cochrane Eyes and Vision US satellite database, 138 potentially relevant systematic reviews were identified, 71 were considered eligible, and 26 (37%) were assessed as reliable. Among reliable systematic reviews, no conclusive evidence was identified for any dry eye intervention. Inconclusive evidence suggested that environmental modifications, dietary modifications, artificial tears and lubricants, punctal occlusion, intense pulsed light therapy, vectored thermal pulsation therapy (Lipiflow), topical corticosteroids, topical cyclosporine A, topical secretagogues, and autologous serum may be effective. Only unreliable systematic reviews evaluated lifitegrast, oral antibiotics, and moisture chamber devices. CONCLUSIONS AND RELEVANCE: This overview of systematic reviews found some evidence that dry eye interventions may be effective, but no conclusive evidence was available. The conduct and reporting of most systematic reviews for dry eye interventions warrant improvement, and reliable systematic reviews are needed to evaluate lifitegrast, oral antibiotics, and moisture chamber devices.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. McCann P, Kruoch Z, Lopez S, et al. Interventions for Dry Eye: An Overview of Systematic Reviews. JAMA Ophthalmol. 2024. PMID: 38127364. doi:10.1001/jamaophthalmol.2023.5751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。